Midwest Research Group/St. Charles Psychiatric Associates is conducting a clinical trial of medication for women between the ages of 18 and 45 who are diagnosed with Post-partum Depression. This study site is one of ten in the country using Brexanolone, a neural steroid which helps to replace the drop in allopregnanolone levels which are known to occur post-partum. This medication has been granted Breakthrough Therapy designation by the FDA. 

Participants must be less than 6 months post-partum, and experienced depression onset that began no earlier than the third trimester and no later than the first four weeks following delivery.

Participants in this study may receive study medication or placebo, physician consultation, travel expenses and compensation for their time.  No insurance required.

Please visit MidwestResearchGroup.com or call 636-946-8032 and speak with Nicole or text 636-486-1930 and complete a short form.

Midwest Research Group     4801 Weldon Spring Parkway #300     St. Charles, MO 63304